Tugba Kos
Overview
Explore the profile of Tugba Kos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kahraman S, Bardakci M, Aykan M, Yasar S, Erol C, Hizal M, et al.
J Cancer Res Ther
. 2023 Apr;
19(2):347-354.
PMID: 37006071
Objective: Neuroendocrine neoplasms (NENs) originate from the diffuse neuroendocrine cell system and constitute a heterogeneous group of tumors exhibiting diverse clinical and biological characteristics. NENs include well-differentiated neuroendocrine tumors (NETs)...
2.
Ulas A, Avci N, Kos T, Cubukcu E, Olmez O, Bulut N, et al.
J BUON
. 2015 Jul;
20(3):714-22.
PMID: 26214622
Purpose: To investigate whether the pretreatment neutrophil lymphocyte ratio (NLR) and the platelet lymphocyte ratio (PLR) have any prognostic significance in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab....
3.
Ulas A, Kos T, Avci N, Cubukcu E, Olmez O, Bulut N, et al.
Asian Pac J Cancer Prev
. 2015 Mar;
16(4):1643-9.
PMID: 25743846
Background: The aim of the present study was to evaluate clinicopathological characteristics of our early stage breast cancer patients who are epidermal growth factor receptor 2 (HER2) overexpressed/ amplified (HER2+),...
4.
Umit Unal O, Oztop I, Kos T, Assoc , Turan N, Kucukoner M, et al.
Asian Pac J Cancer Prev
. 2014 Dec;
15(22):9687-92.
PMID: 25520089
Background: Biliary tract cancers are rare, and surgical resection is the standard treatment at early stages. However, reports on the benefits of adjuvant treatment following surgical resection are conflicting. This...
5.
Akinci M, Sendur M, Aksoy S, Yazici O, Ozdemir N, Kos T, et al.
Asian Pac J Cancer Prev
. 2014 May;
15(8):3377-81.
PMID: 24870725
Background: The incidence of colorectal cancer increases with vitamin D deficiency as shown in recently published studies. In addition, prospective investigations have indicated that low vitamin D levels may be...
6.
Seker M, Kos T, Ozdemir N, Seker A, Aksoy S, Uncu D, et al.
Asian Pac J Cancer Prev
. 2014 Feb;
15(1):327-30.
PMID: 24528050
Background: Ewing sarcoma is a small round cell tumor arising from soft tissue and bone that predominantly affects children and adolescents. The most unfavorable prognostic factor is the presence of...
7.
Uncu D, Aksoy S, Cetin B, Yetisyigit T, Ozdemir N, Berk V, et al.
Oncology
. 2013 Feb;
84(4):240-5.
PMID: 23392240
Objective: The aim of this study was to assess the use of 5-fluorouracil (5-FU), leucovorin and oxaliplatin (FOLFOX) regimens in clinical practice according to their efficacy and toxicity. Methods: Patients...
8.
Civelek B, Aksoy S, Kos T, Seker M, Arik Z, Sendur M, et al.
J Gastrointest Cancer
. 2011 Jul;
43 Suppl 1:S64-6.
PMID: 21761128
No abstract available.